My career has been an adventure

2018 ◽  
Vol 182 (1) ◽  
pp. i-ii

Having worked in the veterinary pharmaceutical industry, vet David Renney set up his own company to explore a niche area that involves bringing new or neglected ideas, products and technologies to the veterinary market.


2019 ◽  
Vol 14 (5) ◽  
pp. 215-238
Author(s):  
Clara Ludmilla Pereira Brasil Comunello ◽  
Alcides Barrichello ◽  
Rogerio Scabim Morano


1978 ◽  
Vol 8 (2) ◽  
pp. 299-328 ◽  
Author(s):  
Sanjaya Lall ◽  
Senaka Bibile

This paper describes the experience of Sri Lanka in reforming the structure of production, importation, and distribution of pharmaceuticals in the period 1972–1976. It highlights the actions and reactions of transnational pharmaceutical corporations to these reforms, and traces the achievements and problems of the State Pharmaceuticals Corporation which was set up to implement the reforms. The roles of political leadership in regulating the power of drug transnationals, and of the medical profession in resisting reform, seem to be of crucial significance. Developing countries wishing to lower the present high cost of drug delivery must proceed with great care and immense caution, since complex problems of quality control, bioequivalence, medical acceptance, and consumer reeducation are involved.



2016 ◽  
Vol 22 (2_suppl) ◽  
pp. 4-8 ◽  
Author(s):  
Patrick Vermersch ◽  
Louis Smets ◽  
Ralf Gold

Background: In the increasingly complex environment of MS there is a need for better cross-talk and communication between the different stakeholders who each address MS according to their own perspective. Objective & Methods: The first and second Pan-European MS Multi-stakeholder Colloquia were specifically set-up for this. Results: In May 2014 and May 2015, the different stakeholders in MS (patients, healthcare professionals, regulators, payers and pharmaceutical industry professionals) met to present and discuss each other’s perspective, formulate 10 integrated Calls to Actions (first Colloquium) and discuss guidance propositions/recommendations developed by working groups for the Calls to Action (second Colloquium). Conclusion: The perspectives of the different stakeholders and the 10 integrated Calls to Action are summarised in this supplement.



Cold chains are normal in the sustenance and pharmaceutical industry and furthermore in some component shipments. One general temperature run for a virus chain in pharmaceutical businesses is 2 to 8 °C. yet, the precise temperature (and time at warmth) resistances rely upon the real creation being transported. Interesting to new create cargoes, the virus chain requires to also keep up item explicit condition parameters which incorporate air quality levels (carbon dioxide, oxygen, dampness and others), which makes this the most convoluted virus chain to work. The general target of this examination is to evaluate the issues looked by cargo forwarders in virus chain supply coordinations on security of immunizations in pharmaceutical merchants. Different goals are to decide how stockpiling conditions in pharmaceutical merchants impacts wellbeing of immunizations, assess the impact of bundling in pharmaceutical wholesalers on the security of antibodies and to set up the degree to which specialized limit in pharmaceutical wholesalers impact wellbeing of Vaccines.



Author(s):  
H. D. Harvas

Production of veterinary pharmacy plays an important role both in animal care and public health, such as for food safety or animal origin to prevent the spread of diseases transmitted to humans through animals. The European market for Animal Health develops rapidly filled with innovative products, updated regulatory system at the legislative level, in order to protect human health, animals and the environment. Today, the focus of attention in the European Union (EU) on the pharmaceutical industry – Is the improvement of the legal framework and its adaptation to the needs and characteristics of the veterinary pharmaceutical industry in particular. Thus Ukraine today - is an intensive process of harmonization, implementation and, at the same time, improvement of the regulatory system, in which international regulatory documents are the basis for the creation of the veterinary pharmaceutical legislation of Ukraine, according to EU requirements.



2001 ◽  
Vol 05 (17) ◽  
pp. 408-412

Eastern China's Zhejiang Province to Set Up Biomedical Park. India's Wheat Exports Hit New Lows. Steady Development of China's Pharmaceutical Industry. Australia's New AIDS Vaccine to Enter Human Trials Next Year. Singapore Continues to Face Shortage of Nurses. More Chinese Couples Hope to Store Embryos for Future Use. Bioscience Symposium Opens in Taiwan.



Author(s):  
Nikita Vijay Jadhav ◽  
Nisha Singh ◽  
Monika Targhotra ◽  
Meenakshi K. Chauhan

Background: As countries and associations, a similar continue contemplating the phenomenal troubles flung by the novel coronavirus (COVID-19), a specific zone of concern has been the defenselessness incorporating the impact of the COVID-19 pandemic on the overall similarly as Indian pharma industry agilely chains. The COVID-19 emergency has featured the significance of having a hazard the executive’s structure set up that centers around the assessment of potential issues emerging from the passing of a flexible chain accomplice or area. Objective: This review focuses on the role of the Indian pharmaceutical industry towards the pandemic. This review investigates the economic effect of COVID-19 across segments and what it implies for the Indian economy. Method: The COVID 19 flare-up has additionally commenced the Indian pharmaceutical organizations an opportunity to transform into a supported trade place point for gathering drugs and intermediates. Result: An enormous pharmaceutical industry in India has consistently been a foundation of reasonable human services, and this pattern would now be able to be required to heighten further. Conclusion: The activities from COVID-19 are with a need to change the overall impression of Indian pharmaceutical associations and even more altogether, reduce the dependence of the private pharma associations on alone suppliers like China.



2020 ◽  
Vol 186 (7) ◽  
pp. 225-225
Author(s):  
Paul Evans

After working in a successful small animal practice, he joined the pharmaceutical industry. He became an author of books for pet owners and the profession, and set up the Pet Health Counsellor programme.



Sign in / Sign up

Export Citation Format

Share Document